The contractor shall provide comprehensive clinical site and study monitoring services for the nccih-funded (primary or secondary) extramural clinical studies research portfolio.

Ended Definitive Contract Awarded Last action

Contract number
75N91021C00033
Awardee
Awarding agency
Obligated
$3,109,345

Award facts

Contract value 100% obligated
$3,109,345.32 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition · 3 offers Negotiated Proposal / Quote
Pricing
Cost Plus Fixed Fee
Place of performance
Rockville, MD 20850, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00007 · To deobligate the remaining FY21 expiring funds in the amount of $1,121.68 from line 1. -$1,122
Exercise an Option P00006 · Exercise option year 4 $193,451
Supplemental Agreement for work within scope P00005 · EOI:: implementing the president's department of government efficiency cost efficiency initiative (march 19, 2025)::EOI. $0
Exercise an Option P00004 $764,568
Exercise an Option P00003 $746,782
Exercise an Option P00002 $710,445
Other Administrative Action P00001 $0
Original award $695,221

About this award

The National Cancer Institute awarded a definitive contract to Westat, Inc. for comprehensive clinical site and study monitoring services supporting the National Center for Complementary and Integrative Health's extramural clinical research portfolio on August 1, 2021, with a ceiling value of $3,109,345.32.

The originating solicitation, posted March 8, 2021 and due April 7, 2021, required qualified clinical, supervisory, and IT personnel to develop standard operating procedures, training programs, and quality control plans supporting the agency's clinical oversight committees for up to 50 clinical research sites annually. Place of performance is throughout the United States, with an estimated 75% of site visits conducted remotely.

The contract carries a one-year base period with four one-year options. The pricing structure is cost plus fixed fee. NAICS 541715 and PSC R425 apply.

Service Contract Inventory reporting shows an actual labor footprint of 2.3 FTEs in the most recent fiscal year (FY2025), with invoiced government-paid labor averaging $126.21/hr (FY2022), $128.87/hr (FY2023), and $123.12/hr (FY2024) across contractor hours. The contract trended roughly flat in hourly rates year-over-year. Westat self-performed all reported hours with no subcontractors engaged.

Quick answers

Who was awarded contract 75N91021C00033?

75N91021C00033 was awarded to Westat, Inc. by National Cancer Institute (National Institutes of Health) on August 1, 2021.

How much is contract 75N91021C00033 worth?

The government has obligated $3,109,345 on 75N91021C00033.

Was contract 75N91021C00033 competed?

The extent of competition for 75N91021C00033 was full and open competition. The government received 3 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award